Cure My Disease

Don't miss your cure!

 Log in / Sign up

New DNA test could sharpen hepatitis b monitoring

NCT ID NCT07684209

Not yet recruiting Diagnosis Sponsor: Beijing Municipal Administration of Hospitals Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study compares a new, more precise digital PCR test with the standard test for measuring hepatitis B virus levels in people with chronic hepatitis B. Researchers will use leftover blood samples from about 200 patients to see if the new method matches the standard test's accuracy, especially for low virus levels. The goal is to find a better way to track the virus and guide treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If the digital PCR method proves consistent with the standard test, it could offer a more precise and accessible way to monitor hepatitis B virus levels.
What could go wrong
This is a small, early-stage comparison study, not a treatment trial. The new method may not prove reliable enough to replace the existing test in clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic hepatitis B virus infection hepatitis B virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC HEPATITIS B

Contacts and locations

Locations

  • Beijing Ditan Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100015, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.